Amarin Corp Plcuk (AMRN) Interest Expenses (2015 - 2017)
Amarin Corp Plcuk (AMRN) posted quarterly Interest Expenses of $5000.0 for Q1 2017, down 95.87% YoY from $121000.0 in Q1 2016, and down 99.97% sequentially from $18.3 million in Q4 2016.
Amarin Corp Plcuk (AMRN) Interest Expenses (2015 - 2017) Analysis & Trends
Amarin Corp Plcuk has disclosed Interest Expenses across 3 years of filings, most recently posting $5000.0 for Q1 2017.
- In Q1 2017, Interest Expenses fell 95.87% year-over-year to $5000.0; the TTM figure through Dec 2017 stood at $5000.0 (down 99.97% YoY), while the FY2025 annual figure was $7000.0, changed 0.0% from the prior year.
- Interest Expenses slipped to $5000.0 in Q1 2017, from $18.3 million in the prior quarter.
- Over the last five years, Interest Expenses for AMRN reached as high as $20.0 million in Q4 2015 and fell as low as $5000.0 in Q1 2017.
- The 3-year median for Interest Expenses is $121000.0 (2016), against an average of $5.5 million.
- Annual changes were most pronounced in 2016 — Interest Expenses fell 5.47% — and 2017, when it sank 95.87%.
- A 3-year view of Interest Expenses shows it stood at $20.0 million in 2015, then dropped by 8.73% to $18.3 million in 2016, then tumbled by 99.97% to $5000.0 in 2017.
- According to Business Quant data, Interest Expenses over the past three periods registered $5000.0, $18.3 million, and $78000.0 for Q1 2017, Q4 2016, and Q3 2016 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 272.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -393.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 657.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 240.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -343.00 Mn |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 5,000.00 |
| Mar 31, 2017 | 5,000.00 |
| Dec 31, 2016 | 18.30 Mn |
| Dec 31, 2016 | 18.30 Mn |
| Sep 30, 2016 | 78,000.00 |
| Sep 30, 2016 | 78,000.00 |
| Mar 31, 2016 | 121,000.00 |
| Mar 31, 2016 | 121,000.00 |
| Dec 31, 2015 | 20.05 Mn |
| Dec 31, 2015 | 20.05 Mn |
| Sep 30, 2015 | 102,000.00 |
| Sep 30, 2015 | 102,000.00 |
| Mar 31, 2015 | 128,000.00 |
| Mar 31, 2015 | 128,000.00 |